Device / Technology News

RSS

NCPDP pleased with HHS' adoption of SCRIPT Standard to achieve Meaningful Use

The National Council for Prescription Drug Programs (NCPDP) today acknowledges and applauds the U.S. Health and Human Services Department (HHS) on its Final Rules announcement on "meaningful use" of an Electronic Health Record (EHR), including the adoption of NCPDP SCRIPT Standard for the secure, electronic transmission of prescriptions and prescription-related information.

14 Jul 2010

MTBC welcomes final rule on meaningful use of EHR

MTBC, a unique healthcare IT company, welcomed today's release by the U.S. Department of Health and Human Services of the final rule on what constitutes "meaningful use" of an Electronic Health Record.

14 Jul 2010

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced a study showing how the TheraDoc clinical surveillance system helped clinicians at Memorial Hospital Miramar reduce catheter-related infections, which correlated with an increase in infection-control interventions.

14 Jul 2010

New prediction tool may determine patients' risk for ductal carcinoma

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike.

14 Jul 2010

NCCS supports two final rules issued by CMS, ONC for EHR incentive programs

The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.

14 Jul 2010

No World Borders sponsors Workgroup for Electronic Data Interchange conference

No World Borders, Inc., a leading health care IT and management consulting firm, today announced that it is a sponsor of the Workgroup for Electronic Data Interchange (WEDI) conference in Fairfax, today through July 15, 2010.

14 Jul 2010

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

New England Biolabs has expanded its line of reagents for sample preparation with the introduction of NEBNext Quick DNA Sample Prep Reagent Set 2 and Master Mix Set 2, both suitable for library construction for Roche's 454 GS FLX Titanium and GS Junior instruments. These new products provide all the necessary enzymes and buffers for fast fragment library preparation.

From New England Biolabs 14 Jul 2010

Brookhaven Science Associates, BioSET receive U.S. patent for tissue regeneration technology

Brookhaven Science Associates, the company that manages the U.S. Department of Energy's Brookhaven National Laboratory, and Biosurface Engineering Technologies, Inc. of Rockville, Maryland, have been issued a U.S. patent for an improved second-generation technology for designing synthetic peptides that are important for tissue regeneration.

14 Jul 2010

Evidence-based guidelines could help prevent dangerous radiation overdoses, says MedSolutions

Utilization management programs that use evidence-based guidelines to ensure appropriate use of diagnostic imaging tests could help prevent dangerous radiation overdoses like the one highlighted in a recent New England Journal of Medicine editorial, said MedSolutions, a leading provider of medical management services.

14 Jul 2010

InQ Biosciences to launch fully integrated Cell Research System

InQ Biosciences, a provider of innovative technologies for cell growth and research, announced its plans to launch the InQ™ Cell Research System during the fourth quarter of 2010. InQ is the first fully integrated system that creates a high fidelity in vivo environment for studying stem cells, plus nerve, brain, and other mammalian cells for disease research.

14 Jul 2010

Valentus Medical Technologies signs partnership agreement with Medical Tactile for SureTouch technology

Medical Tactile, Inc. and Valentus Medical Technologies, Inc. announced today that Valentus Medical Technologies, Inc., based in Victoria, Canada, has signed a partnership agreement with Medical Tactile, Inc., and has taken on the exclusive Sales & Marketing rights for SureTouch™, the non-invasive digital breast imaging technology, worldwide, with the exception of China.

14 Jul 2010

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

Zogenix, Inc., a privately held pharmaceutical company, announced that it has secured a $35 million debt facility led by Oxford Finance Corporation which also included Silicon Valley Bank. The facility consists of a $25 million term loan and a $10 million revolving line of credit. Concurrently, all existing Zogenix investors, including Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Abingworth Management, and Chicago Growth Partners, have provided an additional $15 million investment.

14 Jul 2010

Baxter to provide transition guide for facilities using Colleague infusion pumps

The U.S. Food and Drug Administration today required Baxter Healthcare Corp. to take specific steps to carry out the April 2010 recall of all Colleague Volumetric Infusion Pumps (CVIP) and to provide customers with a refund, a replacement pump, or lease termination.

14 Jul 2010

Metamark Genetics closes $22M Series B financing

Metamark Genetics, Inc., a molecular diagnostics company addressing a major challenge in cancer medicine, has completed a $22 million Series B financing. Metamark's Prognosis Determinants platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on pivotal translational and commercialization efforts to bring these breakthrough discoveries to cancer patients worldwide.

14 Jul 2010

FDA clears Meridian Bioscience's new illumigene C. difficile molecular amplification assay

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene™ C. difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon.

14 Jul 2010

Custom-made bone replacements for facial reconstruction soon

Facial reconstruction patients may soon have the option of custom-made bone replacements optimized for both form and function, thanks to researchers at the University of Illinois and the Ohio State University Medical Center.

13 Jul 2010

Stanford Hospital and Clinics completes migration to InterSystems Ensemble platform

InterSystems Corporation today highlighted the successful completion of an enterprise-scale integration initiative at Stanford Hospital and Clinics (SHC). With the migration from legacy integration software to the InterSystems Ensemble® rapid integration and development platform, SHC is now processing more than 2.2 million HL7 messaging transactions on a daily basis.

13 Jul 2010

Researchers use topological optimization to design facial bone replacements

Scientists are using the engineering technology behind the creation of high-performance aircraft components to design 3-D models for the replacement of delicate and complex facial bones lost to cancer surgery or trauma.

13 Jul 2010

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

EraGen Biosciences Inc., Madison, Wis., was congratulated today by SeqWright, Inc., Houston, on EraGen's successful FDA 510(k) market clearance of its MultiCode-RTx HSV 1 & 2 Kit. This new kit is the first FDA-cleared PCR-based qualitative in vitro diagnostic test for the detection and typing of HSV-1 and HSV-2 from vaginal lesion swab specimens in symptomatic female patients.

13 Jul 2010

Astra Tech expands Atlantis patient-specific abutment options

Astra Tech expands the Atlantis patient-specific abutment options to include Dentsply Friadent's XiVE and Frialit implants and Straumann's Standard/Standard Plus (Wide Neck) implants for North American customers.

13 Jul 2010

Device / Technology News

NCPDP pleased with HHS' adoption of SCRIPT Standard to achieve Meaningful Use

MTBC welcomes final rule on meaningful use of EHR

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

New prediction tool may determine patients' risk for ductal carcinoma

NCCS supports two final rules issued by CMS, ONC for EHR incentive programs

No World Borders sponsors Workgroup for Electronic Data Interchange conference

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

Brookhaven Science Associates, BioSET receive U.S. patent for tissue regeneration technology

Evidence-based guidelines could help prevent dangerous radiation overdoses, says MedSolutions

InQ Biosciences to launch fully integrated Cell Research System

Valentus Medical Technologies signs partnership agreement with Medical Tactile for SureTouch technology

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

Baxter to provide transition guide for facilities using Colleague infusion pumps

Metamark Genetics closes $22M Series B financing

FDA clears Meridian Bioscience's new illumigene C. difficile molecular amplification assay

Custom-made bone replacements for facial reconstruction soon

Stanford Hospital and Clinics completes migration to InterSystems Ensemble platform

Researchers use topological optimization to design facial bone replacements

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

Astra Tech expands Atlantis patient-specific abutment options

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News